Mesa Laboratories Inc (MLAB)
Pretax margin
Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) | US$ in thousands | -275,648 | -389 | 3,574 | 2,303 | 3,433 |
Revenue | US$ in thousands | 216,187 | 219,080 | 184,335 | 133,937 | 117,687 |
Pretax margin | -127.50% | -0.18% | 1.94% | 1.72% | 2.92% |
March 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $-275,648K ÷ $216,187K
= -127.50%
The pretax margin of Mesa Laboratories Inc has shown a declining trend over the past five years. The company experienced a significant decrease in pretax margin from 2.92% in 2020 to -127.50% in 2024, indicating a negative profitability trend. This negative pretax margin in 2024 suggests that the company's expenses exceeded its revenues before accounting for taxes, leading to a loss before taxes. It is important for Mesa Laboratories Inc to assess its cost structure, revenue streams, and operational efficiency to improve its profitability and return to positive pretax margins in the future.
Peer comparison
Mar 31, 2024
Company name
Symbol
Pretax margin
Mesa Laboratories Inc
MLAB
-127.50%
Ametek Inc
AME
24.66%
Cognex Corporation
CGNX
16.40%
Danaher Corporation
DHR
23.58%
Fortive Corp
FTV
16.73%
Keysight Technologies Inc
KEYS
24.84%
MKS Instruments Inc
MKSI
-59.14%
Roper Technologies Inc. Common Stock
ROP
28.47%
Sensata Technologies Holding NV
ST
0.46%